TY - JOUR AU - Edwards, I. R. AU - Aronson, J. K. PY - 2000 DA - 2000// TI - Adverse drug reactions: definitions, diagnosis, and management JO - Lancet VL - 356 UR - https://doi.org/10.1016/S0140-6736(00)02799-9 DO - 10.1016/S0140-6736(00)02799-9 ID - Edwards2000 ER - TY - JOUR AU - Lazarou, J. AU - Pomeranz, B. H. AU - Corey, P. N. PY - 1998 DA - 1998// TI - Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies JO - Jama VL - 279 UR - https://doi.org/10.1001/jama.279.15.1200 DO - 10.1001/jama.279.15.1200 ID - Lazarou1998 ER - TY - JOUR AU - Giacomini, K. M. AU - Krauss, R. M. AU - Roden, D. M. AU - Eichelbaum, M. AU - Hayden, M. R. AU - Nakamura, Y. PY - 2007 DA - 2007// TI - When good drugs go bad JO - Nature VL - 446 UR - https://doi.org/10.1038/446975a DO - 10.1038/446975a ID - Giacomini2007 ER - TY - JOUR AU - Harpaz, R. AU - DuMouchel, W. AU - LePendu, P. AU - Bauer-Mehren, A. AU - Ryan, P. AU - Shah, N. H. PY - 2013 DA - 2013// TI - Performance of pharmacovigilance signal-detection algorithms for the fda adverse event reporting system JO - Clin Pharmacol Ther VL - 93 UR - https://doi.org/10.1038/clpt.2013.24 DO - 10.1038/clpt.2013.24 ID - Harpaz2013 ER - TY - JOUR AU - Harpaz, R. AU - Vilar, S. AU - DuMouchel, W. AU - Salmasian, H. AU - Haerian, K. AU - Shah, N. H. AU - Chase, H. S. AU - Friedman, C. PY - 2012 DA - 2012// TI - Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions JO - J Am Med Inform Assoc VL - 20 UR - https://doi.org/10.1136/amiajnl-2012-000930 DO - 10.1136/amiajnl-2012-000930 ID - Harpaz2012 ER - TY - JOUR AU - Li, Y. AU - Ryan, P. B. AU - Wei, Y. AU - Friedman, C. PY - 2015 DA - 2015// TI - A method to combine signals from spontaneous reporting systems and observational healthcare data to detect adverse drug reactions JO - Drug Saf VL - 38 UR - https://doi.org/10.1007/s40264-015-0314-8 DO - 10.1007/s40264-015-0314-8 ID - Li2015 ER - TY - STD TI - Leaman R, Wojtulewicz L, Sullivan R, Skariah A, Yang J, Gonzalez G. Towards internet-age pharmacovigilance: extracting adverse drug reactions from user posts to health-related social networks. In: Proceedings of the 2010 Workshop on Biomedical Natural Language Processing. Association for Computational Linguistics: 2010. p. 117–125. ID - ref7 ER - TY - JOUR AU - Nikfarjam, A. AU - Sarker, A. AU - O’connor, K. AU - Ginn, R. AU - Gonzalez, G. PY - 2015 DA - 2015// TI - Pharmacovigilance from social media: mining adverse drug reaction mentions using sequence labeling with word embedding cluster features JO - J Am Med Inform Assoc VL - 22 ID - Nikfarjam2015 ER - TY - JOUR AU - Evans, S. AU - Waller, P. C. AU - Davis, S. PY - 2001 DA - 2001// TI - Use of proportional reporting ratios (prrs) for signal generation from spontaneous adverse drug reaction reports JO - Pharmacoepidemiol Drug Saf VL - 10 UR - https://doi.org/10.1002/pds.677 DO - 10.1002/pds.677 ID - Evans2001 ER - TY - JOUR AU - Rothman, K. J. AU - Lanes, S. AU - Sacks, S. T. PY - 2004 DA - 2004// TI - The reporting odds ratio and its advantages over the proportional reporting ratio JO - Pharmacoepidemiol Drug Saf VL - 13 UR - https://doi.org/10.1002/pds.1001 DO - 10.1002/pds.1001 ID - Rothman2004 ER - TY - JOUR AU - Waller, P. AU - Van Puijenbroek, E. AU - Egberts, A. AU - Evans, S. PY - 2004 DA - 2004// TI - The reporting odds ratio versus the proportional reporting ratio:’deuce’ JO - Pharmacoepidemiol Drug Saf VL - 13 UR - https://doi.org/10.1002/pds.1002 DO - 10.1002/pds.1002 ID - Waller2004 ER - TY - JOUR AU - DuMouchel, W. PY - 1999 DA - 1999// TI - Bayesian data mining in large frequency tables, with an application to the fda spontaneous reporting system JO - Am Stat VL - 53 ID - DuMouchel1999 ER - TY - JOUR AU - Bate, A. AU - Lindquist, M. AU - Edwards, I. R. AU - Olsson, S. AU - Orre, R. AU - Lansner, A. AU - De Freitas, R. M. PY - 1998 DA - 1998// TI - A bayesian neural network method for adverse drug reaction signal generation JO - Eur J Clin Pharmacol VL - 54 UR - https://doi.org/10.1007/s002280050466 DO - 10.1007/s002280050466 ID - Bate1998 ER - TY - JOUR AU - Vilar, S. AU - Harpaz, R. AU - Chase, H. S. AU - Costanzi, S. AU - Rabadan, R. AU - Friedman, C. PY - 2011 DA - 2011// TI - Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis JO - J Am Med Inform Assoc VL - 18 UR - https://doi.org/10.1136/amiajnl-2011-000417 DO - 10.1136/amiajnl-2011-000417 ID - Vilar2011 ER - TY - JOUR AU - Vilar, S. AU - Harpaz, R. AU - Santana, L. AU - Uriarte, E. AU - Friedman, C. PY - 2012 DA - 2012// TI - Enhancing adverse drug event detection in electronic health records using molecular structure similarity: application to pancreatitis JO - PloS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0041471 DO - 10.1371/journal.pone.0041471 ID - Vilar2012 ER - TY - JOUR AU - Vilar, S. AU - Ryan, P. AU - Madigan, D. AU - Stang, P. AU - Schuemie, M. AU - Friedman, C. AU - Tatonetti, N. AU - Hripcsak, G. PY - 2014 DA - 2014// TI - Similarity-based modeling applied to signal detection in pharmacovigilance JO - CPT: Pharmacometrics Syst Pharmacol VL - 3 ID - Vilar2014 ER - TY - JOUR AU - Vilar, S. AU - Tatonetti, N. P. AU - Hripcsak, G. PY - 2015 DA - 2015// TI - 3d pharmacophoric similarity improves multi adverse drug event identification in pharmacovigilance JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep08809 DO - 10.1038/srep08809 ID - Vilar2015 ER - TY - JOUR AU - Fliri, A. F. AU - Loging, W. T. AU - Thadeio, P. F. AU - Volkmann, R. A. PY - 2005 DA - 2005// TI - Analysis of drug-induced effect patterns to link structure and side effects of medicines JO - Nat Chem Biol VL - 1 UR - https://doi.org/10.1038/nchembio747 DO - 10.1038/nchembio747 ID - Fliri2005 ER - TY - JOUR AU - Atias, N. AU - Sharan, R. PY - 2011 DA - 2011// TI - An algorithmic framework for predicting side effects of drugs JO - J Comput Biol VL - 18 UR - https://doi.org/10.1089/cmb.2010.0255 DO - 10.1089/cmb.2010.0255 ID - Atias2011 ER - TY - JOUR AU - Pauwels, E. AU - Stoven, V. AU - Yamanishi, Y. PY - 2011 DA - 2011// TI - Predicting drug side-effect profiles: a chemical fragment-based approach JO - BMC bioinformatics VL - 12 UR - https://doi.org/10.1186/1471-2105-12-169 DO - 10.1186/1471-2105-12-169 ID - Pauwels2011 ER - TY - JOUR AU - Liu, M. AU - Wu, Y. AU - Chen, Y. AU - Sun, J. AU - Zhao, Z. AU - Chen, X. -. w. AU - Matheny, M. E. AU - Xu, H. PY - 2012 DA - 2012// TI - Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs JO - J Am Med Inform Assoc VL - 19 UR - https://doi.org/10.1136/amiajnl-2011-000699 DO - 10.1136/amiajnl-2011-000699 ID - Liu2012 ER - TY - JOUR AU - Zhang, W. AU - Yue, X. AU - Liu, F. AU - Chen, Y. AU - Tu, S. AU - Zhang, X. PY - 2017 DA - 2017// TI - A unified frame of predicting side effects of drugs by using linear neighborhood similarity JO - BMC Syst Biol VL - 11 UR - https://doi.org/10.1186/s12918-017-0477-2 DO - 10.1186/s12918-017-0477-2 ID - Zhang2017 ER - TY - JOUR AU - Dey, S. AU - Luo, H. AU - Fokoue, A. AU - Hu, J. AU - Zhang, P. PY - 2018 DA - 2018// TI - Predicting adverse drug reactions through interpretable deep learning framework JO - BMC Bioinformatics VL - 19 UR - https://doi.org/10.1186/s12859-018-2544-0 DO - 10.1186/s12859-018-2544-0 ID - Dey2018 ER - TY - JOUR AU - Luo, H. AU - Fokoue-Nkoutche, A. AU - Singh, N. AU - Yang, L. AU - Hu, J. AU - Zhang, P. PY - 2018 DA - 2018// TI - Molecular docking for prediction and interpretation of adverse drug reactions JO - Comb Chem High Throughput Screen VL - 21 UR - https://doi.org/10.2174/1386207321666180524110013 DO - 10.2174/1386207321666180524110013 ID - Luo2018 ER - TY - STD TI - FDA’s Adverse Event Reporting System (FAERS). https://open.fda.gov/data/faers/. Accessed 30 June 2019. UR - https://open.fda.gov/data/faers/ ID - ref25 ER - TY - STD TI - Banda J, Evans L, Vanguri R, Tatonetti N, Ryan P, Shah N. Data from: A curated and standardized adverse drug event resource to accelerate drug safety research. Dryad Digital Repository. 2016. https://doi.org/10.5061/dryad.8q0s4. ID - ref26 ER - TY - JOUR AU - Brown, E. G. AU - Wood, L. AU - Wood, S. PY - 1999 DA - 1999// TI - The medical dictionary for regulatory activities (meddra) JO - Drug Saf VL - 20 UR - https://doi.org/10.2165/00002018-199920020-00002 DO - 10.2165/00002018-199920020-00002 ID - Brown1999 ER - TY - JOUR AU - Kim, S. AU - Thiessen, P. A. AU - Bolton, E. E. AU - Chen, J. AU - Fu, G. AU - Gindulyte, A. AU - Han, L. AU - He, J. AU - He, S. AU - Shoemaker, B. A. PY - 2015 DA - 2015// TI - Pubchem substance and compound databases JO - Nucleic Acids Res VL - 44 UR - https://doi.org/10.1093/nar/gkv951 DO - 10.1093/nar/gkv951 ID - Kim2015 ER - TY - JOUR AU - Kuhn, M. AU - Campillos, M. AU - Letunic, I. AU - Jensen, L. J. AU - Bork, P. PY - 2010 DA - 2010// TI - A side effect resource to capture phenotypic effects of drugs JO - Mol Syst Biol VL - 6 UR - https://doi.org/10.1038/msb.2009.98 DO - 10.1038/msb.2009.98 ID - Kuhn2010 ER - TY - JOUR AU - Tatonetti, N. P. AU - Patrick, P. Y. AU - Daneshjou, R. AU - Altman, R. B. PY - 2012 DA - 2012// TI - Data-driven prediction of drug effects and interactions JO - Sci Trans Med VL - 4 UR - https://doi.org/10.1126/scitranslmed.3003377 DO - 10.1126/scitranslmed.3003377 ID - Tatonetti2012 ER - TY - JOUR AU - Szarfman, A. AU - Machado, S. G. AU - O’neill, R. T. PY - 2002 DA - 2002// TI - Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the us fd’s spontaneous reports database JO - Drug Saf VL - 25 UR - https://doi.org/10.2165/00002018-200225060-00001 DO - 10.2165/00002018-200225060-00001 ID - Szarfman2002 ER - TY - STD TI - PubChem Substructure Fingerprint V1.3. ftp://ftp.ncbi.nlm.nih.gov/pubchem/specifications/pubchem_fingerprints.txt. Accessed 30 June 2019. UR - https://ftp.ncbi.nlm.nih.gov/pubchem/specifications/pubchem_fingerprints.txt ID - ref32 ER - TY - STD TI - Zhou D, Bousquet O, Lal TN, Weston J, Schölkopf B. Learning with local and global consistency. In: Advances in Neural Information Processing Systems: 2004. p. 321–328. ID - ref33 ER - TY - JOUR AU - Zhang, W. AU - Yue, X. AU - Huang, F. AU - Liu, R. AU - Chen, Y. AU - Ruan, C. PY - 2018 DA - 2018// TI - Predicting drug-disease associations and their therapeutic function based on the drug-disease association bipartite network JO - Methods VL - 145 UR - https://doi.org/10.1016/j.ymeth.2018.06.001 DO - 10.1016/j.ymeth.2018.06.001 ID - Zhang2018 ER - TY - STD TI - Designated Medical Event (DNE). https://www.ema.europa.eu/en/human-regulatory/post-authorisation/pharmacovigilance/signal-management. Accessed 30 June 2019. UR - https://www.ema.europa.eu/en/human-regulatory/post-authorisation/pharmacovigilance/signal-management ID - ref35 ER - TY - STD TI - Liraglutide: Monograph for Professionals. https://www.drugs.com/monograph/liraglutide.html. Accessed 30 June 2019. UR - https://www.drugs.com/monograph/liraglutide.html ID - ref36 ER - TY - STD TI - Liraglutide: FDA Approved Drug Products. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overviewprocess&ApplNo=022341. Accessed 30 June 2019. UR - https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overviewprocess&ApplNo=022341 ID - ref37 ER - TY - STD TI - Liraglutide: European Medicines Agency. https://www.ema.europa.eu/en/medicines/human/EPAR/victoza. Accessed 30 June 2019. UR - https://www.ema.europa.eu/en/medicines/human/EPAR/victoza ID - ref38 ER - TY - STD TI - Liraglutide: FDA Approved Drug Products Safety Label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022341s004lbl.pdf. Accessed 30 June 2019. UR - https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022341s004lbl.pdf ID - ref39 ER - TY - STD TI - Pazopanib: Uses, Side Effects and Warnings. https://www.drugs.com/mtm/pazopanib.html. Accessed 30 June 2019. UR - https://www.drugs.com/mtm/pazopanib.html ID - ref40 ER - TY - STD TI - Pazopanib: FDA Approved Drug Products. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=022465. Accessed 30 June 2019. UR - https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=022465 ID - ref41 ER - TY - STD TI - Pazopanib: European Medicines Agency. https://www.ema.europa.eu/en/medicines/human/EPAR/votrient. Accessed 30 June 2019. UR - https://www.ema.europa.eu/en/medicines/human/EPAR/votrient ID - ref42 ER - TY - STD TI - Pazopanib: FDA Approved Drug Products Safety Label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022465s018lbl.pdf. Accessed 30 June 2019. UR - https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022465s018lbl.pdf ID - ref43 ER -